Medfuturesp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-01-25
Share capital
5,000.00 PLN
Activity description

Medfuture offers dietary supplements, including magnesium with vitamin B6, berberine, vitamin D3 + K2 and coenzyme Q10. The company emphasizes transparent ingredients and dosages, along with independent laboratory testing of each batch.

Registered address
Powstańców Śląskich 16-18, 53-314 Wrocław, Poland
Website
medfuture.pl
Phone
Electronic delivery address
AE:PL-70391-78055-EGRUI-25

Financials

Revenue history (in k)

Filing timeliness

6 of 6 financial statements were filed late (the longest delay 738 days for 2021).

  • 202531/07/2026
  • 202427/08/2025
  • 202309/06/2025
  • 202218/12/2024
  • 202122/07/2024
  • 202024/03/2023
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Manufacture of other food products not elsewhere classified73 / 396
Top 18%
Division · Manufacture of food products190 / 767
Top 25%
Sector · Manufacturing2,018 / 12,010
Top 17%
City · Wrocław1,256 / 13,704
Top 9.2%
Voivodeship · Dolnośląskie2,697 / 23,907
Top 11%
Country · Poland37,349 / 297,935
Top 13%

Results vs industry

Revenue
This companyUSD 4.25mMedianUSD 267.96kAverageUSD 5.34m
Net profit
This companyUSD 651.15kMedianUSD 2.20kAverageUSD 365.64k
Operating costs
This companyUSD 3.44mMedianUSD 284.74kAverageUSD 4.73m
Assets
This companyUSD 2.17mMedianUSD 222.59kAverageUSD 4.07m

Industry

Offer

  • Dietary supplements
  • Vitamins
  • Minerals
  • Herbs
  • Juices
  • Ointments
Certifications: GMP

Website technology

Online shop
  • Shopify

Trademarks

Medfuture holds 3 active trademarks registered with the Polish Patent Office. 1 application is pending. 1 mark has expired or was not registered. The first mark was filed in 2020.

MarkNumberClassesStatusProtected until
PURELINE P NUTRITIONZ.5688075Protected Apr 23, 2034
ViveSanumZ.5688085Protected Apr 23, 2034
MedFuture W ZGODZIE Z NATURĄZ.5105085Protected Feb 24, 2030
VITALITY PLUSZ.5688065Application pending –
MedFutureZ.5668655Not registered –
MarkProtected until
PURELINE P NUTRITIONApr 23, 2034
ViveSanumApr 23, 2034
MedFuture W ZGODZIE Z NATURĄFeb 24, 2030
VITALITY PLUS–
MedFuture–

Authorized Representatives

Paweł Stanisław Bajorek – Viceprezes Zarządu
Sebastian Ireneusz Wiśniewski – President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented independently by the only member of the management board. In the case of a multi-member management board, the company is represented by two members of the management board acting jointly or by one member of the management board acting jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Paweł Stanisław Bajorekage 54
50$675.3150%
Sebastian Ireneusz Wiśniewskiage 44
50$675.3150%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2013-02-07.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

11 public aid cases recorded, with a total value of $246,345.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$184.2K
De minimis aid (in accordance with Commission Regulation 2023/2831)
$10,547
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$19,963

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Best Labsp. z o.o.
Norsa Pharmasp. z o.o.
Supplelabsp. z o.o. + limited partnership
Noble Healthsp. z o.o.
Nikalabsp. z o.o.
Efferta Blendssp. z o.o.
Proton Labssp. z o.o.
Health Medicasp. z o.o.
Puromedicasp. z o.o.
Noblepharmasp. z o.o.

FAQ

Last updated: 2026-07-31